Tilray Inc Cash Flow Conversion Efficiency

Latest as of May 2026: -0.023x

Tilray Inc cash flow conversion efficiency. Based on the latest financial reports, Tilray Inc (TLRY) has a cash flow conversion efficiency ratio of -0.023x as of May 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-37.47 Million) by net assets ($1.59 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Tilray Inc (2012–2026)

Cash flow conversion efficiency of Tilray Inc from 2012 to 2026. This chart illustrates how Tilray Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Tilray Inc for real-time trading data and today's change.

Tilray Inc Cash Flow Conversion Ratio Explained

Tilray Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Tilray Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tilray Inc ranked by their cash flow conversion efficiency. Also see Tilray Inc stock valuation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Cooper Stnd
NYSE:CPS
0.001x
Hillstone Networks Co Ltd
SHG:688030
-0.042x
Zbom Cabinets Co Ltd
SHG:603801
0.096x
Shenzhen Glory Medical Co Ltd
SHE:002551
0.046x
Yantai Zhenghai Bio-Tech Co Ltd
SHE:300653
0.034x
Hellenic Exchanges - Athens Stock Exchange SA
AT:EXAE
0.162x
Vinh Son Song Hinh Hydropower JSC
VN:VSH
0.063x
Organización Cultiba S.A.B. de C.V
MX:CULTIBAB
-0.023x

Annual Cash Flow Conversion Efficiency for Tilray Inc (2012–2026)

The table below shows the annual cash flow conversion efficiency of Tilray Inc from 2012 to 2026. Review TLRY cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-05-31 $1.59 Billion $-69.14 Million -0.043x +31.73%
2025-05-31 $2.04 Billion $-129.81 Million -0.064x -607.55%
2024-05-31 $4.69 Billion $-42.11 Million -0.009x -609.22%
2023-05-31 $4.49 Billion $7.91 Million 0.002x +105.57%
2022-05-31 $5.60 Billion $-177.26 Million -0.032x -161.85%
2021-05-31 $4.47 Billion $-53.99 Million -0.012x +98.66%
2020-05-31 $276.54 Million $-250.16 Million -0.905x -286.62%
2019-05-31 $199.23 Million $-46.62 Million -0.234x -118.91%
2018-05-31 $-4.76 Million $-5.89 Million 1.237x +194.26%
2017-05-31 $3.42 Million $-4.48 Million -1.313x -4550.71%
2016-05-31 $20.61 Million $-581.74K -0.028x +93.08%
2015-05-31 $8.62 Million $-3.52 Million -0.408x -169.35%
2014-05-31 $249.75K $-37.82K -0.151x +93.57%
2013-05-31 $258.27K $-608.47K -2.356x -1723.12%
2012-05-31 $336.69K $-43.51K -0.129x --

About Tilray Inc

NASDAQ:TLRY USA Drug Manufacturers - Specialty & Generic
Market Cap
$364.59 Million
Market Cap Rank
#13554 Global
#3291 in USA
Share Price
$2.65
Change (1 day)
+3.92%
52-Week Range
$0.78 - $13.94
All Time High
$214.06
About

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and… Read more